High coverage of mass drug administration for lymphatic filariasis in rural and non-rural settings in the Western Area, Sierra Leone

Table 2 Number of persons interviewed by Household or by Location and recalling taking both ivermectin and albendazole by area, day and compliance (%) for Day 1 and Day 2 End Process.

	Sample size as % of treatments	Sample size as % of eligible pop	Day 1: End Process			Day 2 End Process: Hard to Reach			Total Day 1 & 2: End Process
UWA			Interview	Recall	%	Interview	Recall	%	Interview	Recall	%
Household			460	371	80.7	530	418	78.9	990	789	79.7
Location			2734	2332	85.3	2613	2275	87.1	5347	4607	86.2
Subtotal	0.74%	0.86%	3194	2703	84.6	3143	2693	85.7	6337	5396	85.2
RWA
Household			267	236	88.4	281	244	86.8	548	480	87.6
Location			1056	907	85.9	1308	1150	87.9	2364	2057	87.0
Subtotal	1.20%	1.55%	1323	1143	86.4	1589	1394	87.7	2912	2537	87.1
Total	0.84%	1.00%	4517	3846	85.1	4732	4087	86.4	9249	7933	85.8

ISSN: 1756-3305